This research grant proposes studies on two experimental forms of obesity. These are: 1) genetically transmitted obesity in the obese (ob/ob) mouse, the diabetes (db/db) mouse and the fatty (Zucker) rat, and 2) hypothalamic obesity. The studies on genetic forms of obesity have been framed to test thehypothesis that the alterations in the endocrine system may be the primary biochemical defect in this system. Three approaches will be used to examine the endocrine hypothesis for genetic obesity. Adrenalectomy has been shown to stop the developoment of many features of this syndrome. The possibility that the primary defect of these mice is in the pituitary-adrenal system will be tested. To explore this question the effects of adrenalectomy will be studied in vivo. In addition, Hepatic cell cultures will be employed to provide an in vitro approach to delineating this possibility more precisely. A second approach will study the concentration of neurotransmitters, especially the peptides in the hypothalamus for which radioimmunoassays are available. Among the peptides which will be examined are cholecystokinin, bombesin, neurotensin, and nerve growth factor. Studies on the development of the brain will also be initiated. The third approach will examine the function of the sympathetic nervous system during stress. Studies on hypothalamic obesity will test the hypothesis that this syndrome results from an altered balance between the sympathetic and parasympathetic components of the autonomic nervous system. The first approach will compare unilateal sympathectomy with and without unilateral hypothalamic lesions. A second approach will explore therole of transplantd pancreatic islets made before or after the introduction of hypothalamic lesions. The concentration and turnover of catecholamines will be measured under a variety of experimental conditions in animals with hypothalamic obesity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK031988-04S1
Application #
3230460
Study Section
Metabolism Study Section (MET)
Project Start
1982-04-01
Project End
1986-11-30
Budget Start
1986-06-01
Budget End
1986-11-30
Support Year
4
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Smith, B K; Andrews, P K; York, D A et al. (1999) Divergence in proportional fat intake in AKR/J and SWR/J mice endures across diet paradigms. Am J Physiol 277:R776-85
Koegler, F H; York, D A; Bray, G A (1999) The effects on feeding of galanin and M40 when injected into the nucleus of the solitary tract, the lateral parabrachial nucleus, and the third ventricle. Physiol Behav 67:259-67
Smith, B K; York, D A; Bray, G A (1998) Chronic d-fenfluramine treatment reduces fat intake independent of macronutrient preference. Pharmacol Biochem Behav 60:105-14
Tsujii, S; Bray, G A (1998) A beta-3 adrenergic agonist (BRL-37,344) decreases food intake. Physiol Behav 63:723-8
Smith, B K; West, D B; York, D A (1997) Carbohydrate versus fat intake: differing patterns of macronutrient selection in two inbred mouse strains. Am J Physiol 272:R357-62
Bray, G A (1993) The nutrient balance hypothesis: peptides, sympathetic activity, and food intake. Ann N Y Acad Sci 676:223-41
Egawa, M; Yoshimatsu, H; Bray, G A (1993) Effect of beta-endorphin on sympathetic nerve activity to interscapular brown adipose tissue. Am J Physiol 264:R109-15
Yoshimatsu, H; Egawa, M; Bray, G A (1993) Sympathetic nerve activity after discrete hypothalamic injections of L-glutamate. Brain Res 601:121-8
Bray, G A (1992) Genetic, hypothalamic and endocrine features of clinical and experimental obesity. Prog Brain Res 93:333-40;discussion 340-1
Yoshimatsu, H; Egawa, M; Bray, G A (1992) Effects of cholecystokinin on sympathetic activity to interscapular brown adipose tissue. Brain Res 597:298-303

Showing the most recent 10 out of 28 publications